# A Trial to Learn if Different Doses of REGN7544 Are Safe in Healthy Adult Participants

> **NCT05970718** · PHASE1 · COMPLETED · sponsor: **Regeneron Pharmaceuticals** · enrollment: 80 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** REGN7544
- **DRUG:** Matching Placebo

## Key facts

- **NCT ID:** NCT05970718
- **Lead sponsor:** Regeneron Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-07
- **Primary completion:** 2024-07-22
- **Final completion:** 2024-07-22
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2024-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05970718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05970718, "A Trial to Learn if Different Doses of REGN7544 Are Safe in Healthy Adult Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05970718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*